REGENXBIO Inc.RGNXNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$3.12
Net Income/Share$-3.44
Operating CF/Share$-2.00
Free CF/Share$-2.06
Cash/Share$5.30
Book Value/Share$3.12
Tangible Book/Share$3.12
Equity/Share$3.12
Interest Debt/Share$6.00
CapEx/Share$0.06
Dividend/Share$0.00
Valuation
Market Cap$545.72M
Enterprise Value$755.05M
P/E Ratio-3.13P/S Ratio3.38P/OCF Ratio-5.39
P/FCF Ratio-5.13
P/B Ratio3.45P/TB Ratio3.45
EV/Sales4.68EV/EBITDA-6.29
Graham Valuation
Graham Number--
Graham Net-Net$-1.35
Profitability
Earnings Yield-31.93%FCF Yield-19.48%ROE-78.29%ROIC-34.32%Return on Tangible Assets-33.88%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-2.89%
CapEx/Revenue1.85%
CapEx/Depreciation0.19
SBC/Revenue22.15%
SG&A/Revenue49.92%
R&D/Revenue133.38%
Liquidity & Solvency
Debt/Equity1.66Debt/Assets0.51Debt/Market Cap0.49
Net Debt/EBITDA-1.74
Current Ratio2.66Interest Coverage-3.68xIncome Quality0.58Efficiency
Days Sales Outstanding60 days
Days Payables Outstanding101 days
Days Inventory0 days
Receivables Turnover6.10x
Payables Turnover3.62x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$161.45M
Working Capital$207.40M
Invested Capital$363.73M
Intangibles/Assets0.00%